Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| Vanillylmethanol 4-Sulfate-d3 Sodium Salt | 3-Methoxy-4-(sulfooxy)-benzeneethanol-d3 Sodium Salt | C9H8D3NaO6S | 273.25 | 3-Methoxy-4-(sulfooxy)-benzeneethanol-d3 Sodium Salt
| |
| Vapendavir | BTA 798; 3-Ethoxy-6-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-1,2-benzisoxazole | 439085-51-5 | C21H26N4O3 | 382.46 | BTA 798; 3-Ethoxy-6-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-1,2-benzisoxazole
|
| Vapendavir-d5 | BTA 798-d5; 3-Ethoxy-6-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-1,2-benzisoxazole-d5 | C21H21D5N4O3 | 387.49 | BTA 798-d5; 3-Ethoxy-6-[2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]-1,2-benzisoxazole-d5
| |
| Vapiprost | [1R-[1alpha(Z),2beta,3beta,5alpha]]-7-[5-([1,1-Biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoic Acid; (4Z)-7-[(1R,2R,3S,5S)-5-([1,1-Biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoic Acid; GR 32191; GR 322191; | 85505-64-2 | C30H39NO4 | 477.63 | [1R-[1alpha(Z),2beta,3beta,5alpha]]-7-[5-([1,1-Biphenyl]-4-ylmethoxy)-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoic Acid; (4Z)-7-[(1R,2R,3S,5S)-... |
| Vapreotide | D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-​Tryptophanamide Cyclic (2→7)-disulfide 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane cyclic peptide deriv.; BMY 41606; Octastatin; RC 160; RC 160 (protein) | 103222-11-3 | C57H70N12O9S2 | 1131.37 | D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-​Tryptophanamide Cyclic (2→7)-disulfide 1,2-Dithia-5,8,11,14,17-pe... |
| GSK 1562590 Hydrochloride | N-[(1R)-1-[3-(Aminocarbonyl)[1,1-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide Hydrochloride | 1003878-07-6 | C30H30Cl2N4O4 • HCl | 581.49, 36.46 | N-[(1R)-1-[3-(Aminocarbonyl)[1,1-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide Hydro... |
| Vapreotide Acetate | D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-Tryptophanamide Cyclic (2→7)-disulfide 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, Cyclic Peptide Deriv.; 16: PN: US20020042374 PAGE: 10 Claimed Protein; 20: PN: US6268342 SEQID: 23 Claimed Protein; 3: PN: EP1118336 SEQID: 3 Claimed Protein; BMY 41606; Octastatin; RC 160; RC 160 (protein); | 116430-60-5 | C59H74N12O11S2 | 1191.42 | D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-Tryptophanamide Cyclic (2→7)-disulfide 1,2-Dithia-5,8,11,14,17-penta... |
| GSK 1838705 | 2-[[2-[[1-[(Dimethylamino)ethanoyl]-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-6-fluoro-N-methylbenzamide | 1116235-97-2 | C27H29FN8O3 | 532.57 | 2-[[2-[[1-[(Dimethylamino)ethanoyl]-5-(methyloxy)-2,3-dihydro-1H-indol-6-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-6-fluoro-N-methylbenzamide
... |
| GSK 2033 | 2,4,6-Trimethyl-N-[[3-(methylsulfonyl)[1,1-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide | 1221277-90-2 | C29H28F3NO5S | 591.66 | 2,4,6-Trimethyl-N-[[3-(methylsulfonyl)[1,1-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide
|
| GSK 2193874 | 3-([1,4-Bipiperidin]-1-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide | 1336960-13-4 | C37H38BrF3N4O | 691.62 | 3-([1,4-Bipiperidin]-1-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide
|
Page 5234 of 10017